Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
80.28
-3.84 (-4.56%)
Feb 21, 2025, 4:00 PM EST - Market closed
Globus Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2,519 | 1,568 | 1,023 | 958.1 | 789.04 | Upgrade
|
| Revenue Growth (YoY) | 60.62% | 53.34% | 6.76% | 21.43% | 0.47% | Upgrade
|
| Cost of Revenue | 1,035 | 476.52 | 263.73 | 239.22 | 217.46 | Upgrade
|
| Gross Profit | 1,484 | 1,092 | 759.12 | 718.88 | 571.58 | Upgrade
|
| Selling, General & Admin | 981.05 | 643.41 | 432.12 | 408.15 | 354.76 | Upgrade
|
| Research & Development | 163.75 | 124.01 | 73.02 | 97.35 | 84.52 | Upgrade
|
| Operating Expenses | 1,264 | 818.45 | 522.87 | 524.02 | 456.11 | Upgrade
|
| Operating Income | 219.7 | 273.51 | 236.25 | 194.86 | 115.47 | Upgrade
|
| Interest Expense | -4.19 | - | - | - | - | Upgrade
|
| Interest & Investment Income | - | 20.13 | 14.23 | 9.3 | 13.95 | Upgrade
|
| Currency Exchange Gain (Loss) | -43.29 | 14.26 | -1.02 | -1.42 | -0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.21 | -1.35 | 7.24 | 3.36 | 1.38 | Upgrade
|
| EBT Excluding Unusual Items | 174.43 | 306.55 | 256.71 | 206.09 | 130.53 | Upgrade
|
| Merger & Restructuring Charges | -53.4 | -139.93 | -5.96 | -16.98 | -4.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.79 | -5.39 | -2.78 | -0.59 | Upgrade
|
| Legal Settlements | -0.31 | -0.43 | -2.34 | -5.92 | -0.01 | Upgrade
|
| Pretax Income | 120.72 | 165.39 | 243.02 | 180.41 | 125.9 | Upgrade
|
| Income Tax Expense | 17.74 | 42.52 | 52.85 | 31.22 | 23.61 | Upgrade
|
| Net Income | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade
|
| Net Income to Common | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade
|
| Net Income Growth | -16.19% | -35.39% | 27.47% | 45.86% | -34.10% | Upgrade
|
| Shares Outstanding (Basic) | 136 | 113 | 100 | 101 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 138 | 115 | 103 | 104 | 101 | Upgrade
|
| Shares Change (YoY) | 20.27% | 11.68% | -0.95% | 2.63% | -1.01% | Upgrade
|
| EPS (Basic) | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 | Upgrade
|
| EPS (Diluted) | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 | Upgrade
|
| EPS Growth | -29.91% | -42.16% | 28.47% | 42.57% | -33.55% | Upgrade
|
| Free Cash Flow | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 | Upgrade
|
| Free Cash Flow Per Share | 2.94 | 1.44 | 1.02 | 2.12 | 1.34 | Upgrade
|
| Gross Margin | 58.90% | 69.62% | 74.22% | 75.03% | 72.44% | Upgrade
|
| Operating Margin | 8.72% | 17.44% | 23.10% | 20.34% | 14.63% | Upgrade
|
| Profit Margin | 4.09% | 7.83% | 18.59% | 15.57% | 12.96% | Upgrade
|
| Free Cash Flow Margin | 16.08% | 10.53% | 10.21% | 22.90% | 17.13% | Upgrade
|
| EBITDA | 473.73 | 418.24 | 304.5 | 264.73 | 178.35 | Upgrade
|
| EBITDA Margin | 18.80% | 26.67% | 29.77% | 27.63% | 22.60% | Upgrade
|
| D&A For EBITDA | 254.02 | 144.73 | 68.25 | 69.87 | 62.87 | Upgrade
|
| EBIT | 219.7 | 273.51 | 236.25 | 194.86 | 115.47 | Upgrade
|
| EBIT Margin | 8.72% | 17.44% | 23.10% | 20.34% | 14.63% | Upgrade
|
| Effective Tax Rate | 14.69% | 25.71% | 21.75% | 17.30% | 18.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.